LTRN
Price
$3.42
Change
-$0.07 (-2.01%)
Updated
Apr 17 closing price
Capitalization
36.88M
17 days until earnings call
RXRX
Price
$5.50
Change
+$0.18 (+3.38%)
Updated
Apr 17 closing price
Capitalization
2.21B
18 days until earnings call
Ad is loading...

LTRN vs RXRX

Header iconLTRN vs RXRX Comparison
Open Charts LTRN vs RXRXBanner chart's image
Lantern Pharma
Price$3.42
Change-$0.07 (-2.01%)
Volume$8.12K
Capitalization36.88M
Recursion Pharmaceuticals
Price$5.50
Change+$0.18 (+3.38%)
Volume$12.77M
Capitalization2.21B
LTRN vs RXRX Comparison Chart
Loading...
LTRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LTRN vs. RXRX commentary
Apr 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LTRN is a Hold and RXRX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 19, 2025
Stock price -- (LTRN: $3.42 vs. RXRX: $5.50)
Brand notoriety: LTRN and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LTRN: 19% vs. RXRX: 48%
Market capitalization -- LTRN: $36.88M vs. RXRX: $2.21B
LTRN [@Biotechnology] is valued at $36.88M. RXRX’s [@Biotechnology] market capitalization is $2.21B. The market cap for tickers in the [@Biotechnology] industry ranges from $282.79B to $0. The average market capitalization across the [@Biotechnology] industry is $2.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LTRN’s FA Score shows that 1 FA rating(s) are green whileRXRX’s FA Score has 0 green FA rating(s).

  • LTRN’s FA Score: 1 green, 4 red.
  • RXRX’s FA Score: 0 green, 5 red.
According to our system of comparison, LTRN is a better buy in the long-term than RXRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LTRN’s TA Score shows that 5 TA indicator(s) are bullish while RXRX’s TA Score has 5 bullish TA indicator(s).

  • LTRN’s TA Score: 5 bullish, 3 bearish.
  • RXRX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, LTRN is a better buy in the short-term than RXRX.

Price Growth

LTRN (@Biotechnology) experienced а +12.50% price change this week, while RXRX (@Biotechnology) price change was +21.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.02%. For the same industry, the average monthly price growth was -13.21%, and the average quarterly price growth was -24.46%.

Reported Earning Dates

LTRN is expected to report earnings on May 06, 2025.

RXRX is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+7.02% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($2.21B) has a higher market cap than LTRN($36.9M). LTRN YTD gains are higher at: 7.210 vs. RXRX (-18.639). LTRN has higher annual earnings (EBITDA): -21.18M vs. RXRX (-426.72M). RXRX has more cash in the bank: 594M vs. LTRN (28.1M). LTRN has less debt than RXRX: LTRN (291K) vs RXRX (108M). RXRX has higher revenues than LTRN: RXRX (58.5M) vs LTRN (0).
LTRNRXRXLTRN / RXRX
Capitalization36.9M2.21B2%
EBITDA-21.18M-426.72M5%
Gain YTD7.210-18.639-39%
P/E RatioN/AN/A-
Revenue058.5M-
Total Cash28.1M594M5%
Total Debt291K108M0%
TECHNICAL ANALYSIS
Technical Analysis
LTRNRXRX
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 26 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 11 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
LTRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LSRCX1.570.02
+1.29%
Lord Abbett Small Cap Value C
AGCHX15.290.11
+0.72%
American Century Global Small Cap C
BEGRX15.840.09
+0.57%
Franklin Mutual Beacon Z
VLCAX122.310.18
+0.15%
Vanguard Large Cap Index Admiral
MSKLX9.88-0.03
-0.30%
Morgan Stanley Inst Discovery L

LTRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LTRN has been loosely correlated with RXRX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if LTRN jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LTRN
1D Price
Change %
LTRN100%
-2.01%
RXRX - LTRN
38%
Loosely correlated
+3.38%
ABCL - LTRN
38%
Loosely correlated
+1.26%
ABSI - LTRN
38%
Loosely correlated
+1.31%
CRSP - LTRN
38%
Loosely correlated
-0.03%
ATAI - LTRN
38%
Loosely correlated
+3.52%
More